Medicago, GSK Team Up to Develop Adjuvanted COVID-19 Vaccine, PI to Commence in Mid-July

Medicago, a Canadian subsidiary of Mitsubishi Tanabe Pharma, said on July 8 that it has inked a collaboration agreement with GlaxoSmithKline on the development of an investigational COVID-19 vaccine, combining their antigen and adjuvant. A PI study will kick off...read more